Asia-Pacific injection pen market is projected to grow at a CAGR of 8.1% during the forecast period (2020-2026). The key factors that drive the growth of the market include the rising geriatric population in the region which creates more chances of diseases such as diabetes in the region, which in turn, creates scope for the market growth. Besides, the large population base in economies such as China, India, and Japan also serves as a growth fueling factor for the market. Further, improving healthcare infrastructure is also contributing significantly to the growth of the injection pen market in the region.
Visit for Global Injection Pen Market Report at: https://www.omrglobal.com/industry-reports/injection-pen-market
Asia-Pacific injection pen market is segmented on the basis of type, and disorder type. Based on the type, the market is bifurcated into reusable and disposable. Most of the injectors available today are reusable as these require the replacement of only needles and cartridges. In addition, these can be used for a longer time, which makes them cost-effective. Based on the disorder type, the market is segmented into autoimmune disease, hormonal disorders, orphan disease, and others. The autoimmune disorder which includes diabetes and arthritis is a major application for an injection pen.
Geographically, the Asia-Pacific injection pen market is segmented into China, India, Japan, ASEAN, South Korea, and the Rest of Asia-Pacific. China is anticipated to grow considerably over the forecast period. Further, Mylan N.V., Eli Lily & Co., F. Hoffmann-La Roche Ltd., Pfizer Inc., and GlaxoSmithKline Plc, are some of the prominent players operating in the Asia-Pacific injection pen market. New product launches & developments, partnerships, agreements, and acquisitions are some of the growth strategies adopted by the players in order to sustain in the highly competitive market.
Research Methodology
The market study of the Asia-Pacific injection pen market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
Secondary Sources Include:
The report is intended for medical device manufacturers, injection pen manufacturers, pharmaceutical companies, research institutes and universities, government organizations, regulatory bodies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
Market Segmentation:
The Report Covers:
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Market Determinants
3.1. Motivators
3.2. Restraints
3.3. Opportunities
4. Market Segmentation
4.1. Asia-Pacific Injection Pen Market by Type
4.1.1. Reusable
4.1.2. Disposable
4.2. Asia-Pacific Injection Pen Market by Disorder Type
4.2.1. Autoimmune Disorders
4.2.2. Hormonal Disorders
4.2.3. Orphan Diseases
4.2.4. Others
5. Regional Analysis
5.1. Asia-Pacific
5.1.1. China
5.1.2. India
5.1.3. Japan
5.1.4. Rest of Asia-Pacific
6. Company Profiles
6.1. AstraZeneca Plc
6.1.1. Overview
6.1.2. AstraZeneca Plc in Asia-Pacific
6.1.3. AstraZeneca Plc in Injection Pen Landscape
6.1.4. Recent Developments
6.2. Eli Lilly and Co.
6.3. F. Hoffmann-La Roche Ltd.
6.4. Gerresheimer AG
6.5. GlaxoSmithKline Plc
6.6. Mylan N.V.
6.7. Novartis International AG
6.8. Novo Nordisk AS
6.9. Owen Mumford Ltd.
6.10. Pfizer Inc.
6.11. Solteam Incorporation Co., Ltd.
1. ASIA-PACIFIC INJECTION PEN MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
2. ASIA-PACIFIC REUSABLE INJECTION PEN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
3. ASIA-PACIFIC DISPOSABLE INJECTION PEN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
4. ASIA-PACIFIC INJECTION PEN MARKET RESEARCH AND ANALYSIS BY DISORDER TYPE, 2019-2026 ($ MILLION)
5. ASIA-PACIFIC INJECTION PEN FOR AUTOIMMUNE DISORDERS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
6. ASIA-PACIFIC INJECTION PEN FOR HORMONAL DISORDERS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
7. ASIA-PACIFIC INJECTION PEN FOR ORPHAN DISEASES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
8. ASIA-PACIFIC INJECTION PEN FOR OTHER DISEASES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
9. ASIA-PACIFIC INJECTION PEN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
1. ASIA-PACIFIC INJECTION PEN MARKET SHARE BY TYPE, 2019 VS 2026 (%)
2. ASIA-PACIFIC INJECTION PEN MARKET SHARE BY DISORDER TYPE, 2019 VS 2026 (%)
3. ASIA-PACIFIC INJECTION PEN MARKET SHARE BY COUNTRY, 2019 VS 2026 (%)
4. CHINA INJECTION PEN MARKET SIZE, 2019-2026 ($ MILLION)
5. INDIA INJECTION PEN MARKET SIZE, 2019-2026 ($ MILLION)
6. JAPAN INJECTION PEN MARKET SIZE, 2019-2026 ($ MILLION)
7. ASEAN INJECTION PEN MARKET SIZE, 2019-2026 ($ MILLION)
8. SOUTH KOREA INJECTION PEN MARKET SIZE, 2019-2026 ($ MILLION)
9. REST OF ASIA-PACIFIC INJECTION PEN MARKET SIZE, 2019-2026 ($ MILLION)